Blog

AI: Advancing Patient Access and Outcomes

Biocom’s 4th Annual Big Data Summit, held October 29, 2019 in La Jolla, CA, brought together thought leaders in artificial intelligence (AI), computational drug discovery, and blockchain technology. Throughout the day a recurring theme emerged: machine learning improves the affordability, speed, quality and utility of complex applications. Technology advancements over the last 5 years have …

AI: Advancing Patient Access and Outcomes Read More »

AACR Highlights: Focus on AI

The 110th Annual Meeting of the American Association for Cancer Research launched on March 30th, 2019 in Atlanta, GA. Over 22,000 delegates attended including scientists, clinicians, and patient advocates from around the globe. A team from Reveal Biosciences was present to highlight our recent advances in the application of artificial intelligence (AI) in pathology for …

AACR Highlights: Focus on AI Read More »

Inside the Slide: Episode 1

We are proud to present the premier episode of our “Inside the Slide” video series. In this first episode, we examine a whole slide image of a prostate tissue sample stained with hemotoxylin and eosin (H&E). In the coming months, we will explore more whole slide images of different tissue types and staining techniques we …

Inside the Slide: Episode 1 Read More »

Pre-Clinical Efficacy Models for Immuno-Oncology Studies in Humanized Mice

Reveal Biosciences attended Biocom’s recent CRO seminar on Pre-Clinical Efficacy Models for Immuno-Oncology Studies in Humanized Mice. Pharmatest Services and Taconic Biosciences hosted this informative seminar where they presented on humanized immune system models for immunotherapies and on humanized mouse models of bone metastasis. Paul Volden, Associate Director of External Collaboration and Innovation at Taconic …

Pre-Clinical Efficacy Models for Immuno-Oncology Studies in Humanized Mice Read More »

Tech Spotlight: Meet the Tech Exec Interview with Dr. Claire Weston

Reveal Biosciences Founder and CEO, Dr. Claire Weston, was recently featured in the Tech Spotlight interview series. This interview covered topics such as the inception of Reveal Biosciences, the future impact of AI on pathology, and more. You can read the full interview on the Managed Solution website by clicking here. Here’s Claire’s response to …

Tech Spotlight: Meet the Tech Exec Interview with Dr. Claire Weston Read More »

Reveal Biosciences Webinar Recap: Revolutionize Pathology Using Artificial Intelligence

Casey Laris, CTO of Reveal Biosciences, lead a webinar entitled “Revolutionize Pathology using Artificial Intelligence” as part of the Science Exchange Webinar Series. Highlights from this webinar include: Reveal Biosciences specializes in data-driven pathology. The company offers a range of histopathology, immunohistochemistry (IHC), in situ hybridization (ISH), whole slide imaging and advanced image analysis services. …

Reveal Biosciences Webinar Recap: Revolutionize Pathology Using Artificial Intelligence Read More »

Precision Histology: Artificial Intelligence as a Tool for Pathologists

The hematoxylin and eosin (H&E) stain has long been an essential tool in the pathologist’s arsenal. Positively-charged hematoxylin and negatively-charged eosin bind to different substances within a tissue sample. This allows pathologists to clearly view different structures within that sample in various shades of blue, violet, and red. Once stained, the tissue sample can be …

Precision Histology: Artificial Intelligence as a Tool for Pathologists Read More »

United Nations: Making Global Goals Local Business

Athena, a voice for professional women in STEM in Southern California, recently became a signatory of the United Nations Global Compact.  Athena joins over 9,933 companies in 160 countries focused on aligning their strategies and operations with the UN Sustainable Development Goals for human rights, gender equity, labor, environment, and anti-corruption.   In December a …

United Nations: Making Global Goals Local Business Read More »

BIOCOM EVENT: How is AI Benefiting Biopharma?

This BIOCOM event featured a full house with lively discussion as we learned about how Reveal Biosciences and Immuneering Corporation are applying Artificial Intelligence (AI) to benefit biopharma. The speakers were: Casey Laris, CTO, Reveal Biosciences Rebecca Kusko, PhD, SVP & Head of R&D, Immuneering Corporation Casey began the program with an overview of AI, …

BIOCOM EVENT: How is AI Benefiting Biopharma? Read More »

Athena VLOG: Blueprint for Success

Meet our CEO, Dr. Claire Weston, chatting with Holly Smithson, CEO of Athena in their October Blueprint for Success video blog. Athena Mission: To empower progress together by advancing professional women in STEM. About Athena: Athena is empowering progress together by advancing women in the STEM fields.  Athena’s Southern California member community accesses executive leadership …

Athena VLOG: Blueprint for Success Read More »